Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript [The Motley Fool]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: The Motley Fool
Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript Image source: The Motley Fool. Rigel Pharmaceuticals ( NASDAQ:RIGL :00 p.m. ET Contents: : Operator Good afternoon, and welcome to Rigel Pharmaceuticals financial conference call for the fourth-quarter and year-end of 08. [Operator instructions] I would like to remind you that this call is being recorded for replay purposes on Rigel's website. [Operator instructions] And now I would like to turn the conference over to our first speaker, Dolly Vance, who is Rigel's executive vice president, corporate affairs and general counsel. Executive Vice President, Corporate Affairs and General Counsel Welcome to our financial results and business update conference call. The financial press release for the fourth quarter and full year of 08 was issued a short while ago and can be viewed, along with the accompanying slides for this presentation, in the news and events section of our investor relations page on our website,
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma [Yahoo! Finance]Yahoo! Finance
- Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & LymphomaPR Newswire
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
RIGL
Earnings
- 3/5/24 - Beat
RIGL
Sec Filings
- 4/12/24 - Form 8-K
- 4/10/24 - Form ARS
- 4/10/24 - Form DEFA14A
- RIGL's page on the SEC website